BSE filing, NSE: TEJNAKSH. Summary written from the filing by ALFA Finder's alert engine.
Tejnaksh Healthcare Ltd: key numbers
- Share price
- ₹12.45
- Market cap
- ₹25.29 Cr
- Revenue (annual)
- ₹10.79 Cr
- Net profit (annual)
- ₹1.23 Cr
- P/E (TTM)
- 20.4×Sector 53.8×
- Promoter holding
- 73.83%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tejnaksh Healthcare Ltd
All →Tejnaksh Healthcare Business Update
Tejnaksh Healthcare's Managing Director Dr. Ashish Rawandale-Patil was selected as a mentor for ES-TIP 2027. The honour is an international recognition of his medical innovation expertise.
Tejnaksh Healthcare Business Update
Tejnaksh Healthcare announced publication of a multicentric validation study of its Pflow device in the Indian Journal of Urology. The filing is a scientific publication update with no financial value.
Tejnaksh Healthcare Other Announcement
Tejnaksh Healthcare Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with Regulation 31(1)(b) of SEBI LODR.
Tejnaksh Healthcare Management Change
Tejnaksh Healthcare shareholders approved the re-appointment of Mr. Suhas Vasantrao Thorat as an Independent Director for a second five-year term at the 18th Annual General Meeting.
Tejnaksh Healthcare Annual General Meeting
The company issued a notice for its Annual General Meeting scheduled for September 29, 2026, to consider financial statements, director appointments, and related party transaction approvals.
Tejnaksh Healthcare Annual Report
Tejnaksh Healthcare Limited has submitted its Annual Report for the financial year 2025-26. The filing includes audited standalone and consolidated financial statements along with governance reports.
Other debt & borrowing announcements
All →Persistent Systems Debt & Borrowing: ₹7,000 Cr
Persistent Systems Limited approved the allotment of 700,000 non-convertible debentures (NCDs) aggregating to ₹7,000 Crore. The senior rated debt, issued on a private placement basis, carries an 8.95% coupon.
- Value
- ₹7,000 Cr
- Execution
- 2 to 3 years
Hindustan Petroleum Corporation Debt & Borrowing: ₹191 Cr
HPCL paid Rs.191 Crore interest on its 7.64% Series IV NCDs due 4 November 2026. The payment relates to a Rs.2,500 Crore issue.
- Value
- ₹191.0 Cr
Arman Financial Services Debt & Borrowing: ₹387.3 Cr
Arman Financial Services Ltd submitted its asset cover certificate for the quarter ended September 30, 2026. The company maintains a 110% security cover on its outstanding secured non-convertible debentures.
- Value
- ₹387.3 Cr
Bajaj Housing Finance Debt & Borrowing: ₹3,003 Cr
Bajaj Housing Finance allotted 3,00,000 secured NCDs aggregating Rs. 3,002.68 crore via private placement. The 10-year debentures carry an 8.68% annual coupon maturing in November 2036.
- Value
- ₹3,003 Cr
CL Educate Debt & Borrowing: ₹100 Cr
CL Educate issues secured NCDs worth ₹100 Crore at 11.90% p.a. over 50 months. The debentures are listed on BSE's wholesale debt segment.
- Value
- ₹100.0 Cr
- Execution
- 50 months (2026-11-25 to 2031-01-25)
Home First Finance Company India Debt & Borrowing
Home First Finance fixed the record date for part redemption and interest on NCDs (ISIN INE481N07071). ₹5,000 face value per NCD will be redeemed effective 27 Nov 2026.